Home/Saronic Biotechnology/Spiros Hiotis, M.D., Ph.D.

Spiros Hiotis, M.D., Ph.D.

Investor Contact / Likely Founder or Executive

Therapeutic Areas

Drug	Indication	Phase
SBI1997	Hepatocellular Carcinoma (HCC) - Prevention of Recurrence	Preclinical